Novo said last week that CagriSema was "well-tolerated" and that the most common adverse effects were gastrointestinal, but they were "mild to moderate and diminished over time." "Investors are looking for treatment options that are best in class and will secure Novo's place in the obesity drug market," Soren Lontoft, pharma equity analyst at Sydbank, told CNBC over the phone Tuesday
Avoiding foods that are high in fat, spicy, or heavily processed can reduce nausea and discomfort, as these foods take longer to digest and may exacerbate symptoms
Tirzepatide for weight loss in Alpharetta , the team at Geneva Primary Care & Med Spa is ready to help
Combining Sermorelin and Ipamorelin can create a synergistic effect, but this approach should only be used when prescribed by a qualified healthcare provider
02 A plan built around you
Current estimates suggest that within 12-18 months, patients could access semaglutide at roughly one-third to one-half the current brand-name cost. For now, understanding your provincial coverage, exploring private insurance options, taking advantage of manufacturer savings programs, and consulting with healthcare providers about cost-optimization strategies can help you access this transformative medication more affordably